<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

School of Medicine News and Stories

Recognition

Research    Education    Students    Recognition

CU Student's Fertility Research Recognized at International Conference

Thy Nguyen’s passion for medicine is woven from many separate threads – interests in women’s health and community health, in social justice and health equity, and a recognition that complications during pregnancy and infanthood can have long-term impacts on health outcomes.


Author Rachel Sauer | Publish Date April 25, 2023
Full Story

Education    Community    Students    Recognition

Students Honor Those Who Donated Their Bodies for Anatomy Education

Eunice Spackman was born on her family’s high plains homestead near Akron, Colorado. She rode a horse two miles to and from school each day, a path so familiar that the horse wouldn’t deviate from it even when she wanted to go visit a friend.


Author Rachel Sauer | Publish Date April 22, 2022
Full Story

School of Medicine In the News

KKTV

Colorado doctors warning of skyrocketing alcohol use post-pandemic as liver transplants among younger people increase

news outletKKTV
Publish DateFebruary 14, 2024

Colorado doctors say they are concerned about alcohol use after the pandemic, as liver transplants among younger people increase.

More News
Neurology Live

The Evolving Landscape of Treatments for Multiple Sclerosis in 2024: Enrique Alvarez, MD, PhD

news outletNeurology Live
Publish DateFebruary 13, 2024

As the landscape of care evolves in multiple sclerosis (MS), clinicians continue their efforts in optimizing therapeutic approaches for patients. Investigating de-escalation of therapies, which involves transitioning patients from high or moderate efficacy disease-modifying therapies to lower efficacy ones to lower risk of adverse effects, has been a topic of interest.

More News
TCTMD

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

news outletTCTMD
Publish DateFebruary 13, 2024

Cumulative safety data from three trials testing the reversible direct factor XIa inhibitor asundexian in patients at risk for stroke or recurrent cardiovascular events suggest a better bleeding profile compared with apixaban (Eliquis; Bristol Myers Squibb) in a variety of patient types.

More News
CBS News

Flu, COVID, RSV: Colorado doctor says 5% of hospitalized patients have two viruses at the same time

news outletCBS News
Publish DateFebruary 13, 2024

Chances are you or someone you know has gotten sick over the past few weeks or months. 

More News